CombinoNews
Mercado internacional
> ProductosProductos para el mercado internacional
| Molecule | Dosage | Reference product |
|---|---|---|
| Acyclovir Lyophilised powder for injection |
250 mg | Zovirax® (Glaxo SmithKline) |
| Amikacin Solution for injection |
62,5 mg/ml, 125 mg/ml, 250 mg/ml | Amikin® (Bristol Myers Squibb) |
| Amoxycillin + clavulanic acid Powder for injection |
500 mg/50 mg, 1 g/200 mg, 2 g/200 mg | Augmentin® (Glaxo SmithKline) |
| Amphotericin B (Desoxycholate complex) Lyophilised powder for injection |
50 mg | Fungizone Intravenous® (Bristol Myers Squibb) |
| Cefonicid Powder and solvent for injection |
500 mg, 1 g | Monocid® (Glaxo SmithKline) |
| Cefotaxime Powder and solvent for injection Powder for infusion |
500 mg, 1 g 2 g |
Claforan® (Aventis Pharma) |
| Ceftazidime Powder for injection Powder for infusion |
500 mg, 1 g 1 g, 2 g |
Fortum® (Glaxo SmithKline) |
| Ceftriaxone Powder and solvent for injection Powder for infusion |
250 mg, 500 mg, 1 g 2 g |
Rocephin® (Roche) |
| Cefuroxime (Sodium) Powder for injection Powder for infusion |
250 mg, 750 mg 1500 mg |
Zinacef® (Glaxo SmithKline) |
| Clindamycin Solution for injection |
150 mg/ml (300 mg/2 ml, 600 mg/4 ml, 900 mg/6 ml) | Dalacin® (Pharmacia&Upjohn) |
| Cloxacillin Powder for injection |
500 mg, 1 g | Orbenin® (Glaxo SmithKline) |
| Fluconazol Solution for injection |
2 mg/ml (50 ml, 100 ml) | Diflucan® (Pfizer) |
| Flumazenil Solution for injection |
0,1 mg/ ml (5 ml, 10ml) | Anexate® (Roche) |
Note: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. Availability may be restricted to certain markets or countries. September 2007
| Molecule | Dosage | Reference product |
|---|---|---|
| Granisetron Solution for injection |
3 mg/3 ml |
Kytril® (Roche) |
| Iron sucrose Solution for injection/concentrate solution for infusion |
20 mg/ml | Venofer® (Vifor) |
| Ketorolac Tromethamine Solution for injection |
30 mg/ml |
Toradol® (Roche) |
| Levofloxacin Solution for injection |
5 mg/ml (500 mg/100 ml) | Tavanic® (Aventis) |
| Midazolam Solution for injection |
1 mg/ml (5 mg/5 ml), 5 mg/ml (15 mg/3 ml and 50 mg/10 ml) | Hypnovel® (Roche) |
| Pamidronate Lyophilised powder for injection |
15 mg, 30 mg, 60 mg, 90 mg | Aredia® (Novartis) |
| Pantoprazole Lyophilised powder for injection |
40 mg | Pantocarm®, Pantoloc® (Altana Pharma) |
| Pentamidine Lyophilised powder for injection Lyophilised powder for nebuliser solution |
300 mg 300 mg |
Pentacarinat® (JHC Healthcare) |
| Phenytoin Solution for injection |
100 mg/2 ml 250 mg/5 ml |
Phenytoin® (Pfizer/ Rubió) |
| Piperacillin/Tazobactam Lyophilised powder for injection |
2 g/0,25 g, 4 g/0,5 g | Tazobac® (Wyeth) |
| Somatostatin Lyophilised powder for injection |
0,25 mg, 3 mg | Stilamin® (Serono, IT, NL, CH.) Aminopanc® (UCB, DE.) Modustatine® (Clin Midy, FR.) |
| Teicoplanin Lyophilised powder for injection |
200 mg, 400 mg | Targocid® (Aventis Pharma) |
| Vancomycin Lyophilised powder for injection |
500 mg, 1 g | Vancocin® (Lilly) |
| Zidovudine Capsule Oral solution Tablets |
100 mg, 250 mg, 300 mg 50 mg/5 ml 300 mg |
Retrovir® (Glaxo SmithKline) |
Note: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. Availability may be restricted to certain markets or countries. September 2007
| Molecule | Dosage | Reference product |
|---|---|---|
| Acyclovir Cream Tablets |
5 % 800 mg |
Zovirax® (Glaxo SmithKline) |
| Doxazosin Tablets |
2 mg, 4 mg | Cardura® (Pfizer) |
| Fluoxetine Capsules |
20 mg |
Prozac® (Lilly) |
| Gabapentin Tablets Capsules |
600 mg, 800 mg 100 mg, 300 mg, 400 mg |
Neurontin® (Pfizer) |
| Glimepiride Tablets |
1 mg, 2 mg, 3 mg, 4 mg and 6 mg | Amaryl® (Aventis Pharma) |
| Ibuprofen-lysine Oral powder for solution |
600 mg, 400 mg | Algidrin® (Fardi) |
| Mirtazapine Tablets |
15 mg, 30 mg, 45 mg | Rexer® (Organon) |
| Pantoprazole Tablets, delayed release |
20 mg, 40 mg | Pantozol® (Altana Pharma) |
| Glucosamine Sulphate Oral powder for solution |
1500 mg | Xicil® (Rottapharm) |
| Venlafaxine IR Tablets |
37,5 mg, 50 mg, 75 mg | Effexor® (Wyeth) |
Note: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. Availability may be restricted to certain markets or countries. September 2007